Top Markets
#1 GEKKO GEKKO +53.94%
#2 ADO Protocol ADO Protocol +38.59%
#3 Helium Helium +31.91%
#4 Pons Pons +27.36%
#5 TENDIES TENDIES +23.10%
#6 龙虾 (Lobster) 龙虾 (Lobster) +22.10%
#7 Main Street Yield Main Street Yield +17.48%
#8 Nillion Nillion +17.21%
#9 o1.exchange o1.exchange +16.15%
#10 Cysic Cysic +16.00%
Coin of the day
GEKKO GEKKO
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Paragon 28, Inc. Paragon 28, Inc.

Paragon 28, Inc.

FNA
Classifica tra le azioni #9071
Paragon 28, Inc. is a medical device company specializing in the development,... Paragon 28, Inc. is a medical device company specializing in the development, manufacturing, and global distribution of advanced surgical systems tailored for foot and ankle procedures. Its comprehensive product portfolio encompasses a wide array of solutions: Plating Systems: This includes the Gorilla plating series, offering specific solutions for Lisfranc injuries, Lapidus procedures, lateral column corrections, calcaneus slides, and naviculocuneiform (NC) fusions. Complementary products like Baby Gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates, as well as Silverback plating systems, are also available. Precision Guidance Technology: The company provides sophisticated guidance systems to enhance accuracy in various operations, such as fusion procedures for bunion deformities, first tarsometatarsal arthrodesis, metatarsal osteotomy for bunion correction, medial column beaming for Charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. Screw Systems: Paragon 28 offers robust screw systems, including the Monster, Mini Monster, and Joust beaming lines, which are critical for applications like bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, and fracture repair. Joint Replacement Solutions: Their offerings extend to total ankle replacement with the APEX 3D systems, alongside total talus spacers designed to replace the talus bone that links the leg and foot. Bunion/Hallux Valgus Correction Systems: Specifically for bunion management, the company provides nail systems such as the Phantom intramedullary nail systems, targeting severe hallux valgus cases. Orthobiologics: A substantial part of their product line comprises various orthobiologics, including bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix. They also feature PRESERVE bone graft systems for homologous applications. Ancillary Products: The company further supplies soft tissue fixation systems, titanium sprayed polyetheretherketone (PEEK) implants, nitinol staple systems, stabilization solutions, and specialized curved instruments. Paragon 28 distributes its products to hospitals and ambulatory surgery centers through an established network of both direct sales representatives and stocking distributors. Founded in 2010, the company maintains its corporate headquarters in Englewood, Colorado.
Prezzo delle azioni
$13.09
Ultima sincronizzazione: 2025-04-17
Capitalizzazione di mercato
$1.10B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Paragon 28, Inc. (FNA)

Categoria

Healthcare
Rapporto P/E per Paragon 28, Inc. (FNA)
Rapporto P/E al August 2026 TTM: -19.83
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Paragon 28, Inc., il rapporto P/E attuale (TTM) è -19.83. Alla fine del 2023, il rapporto P/E era -17.73.
Storico del rapporto P/E per Paragon 28, Inc. da 2019 a 2026
Rapporto P/E alla fine di ogni anno
Anno Rapporto P/E Cambia
2026 (TTM) -19.83 25.93%
2024 -15.75 -11.19%
2023 -17.73 -18.61%
2022 -21.79 -77.94%
2021 -98.76 -118.56%
2020 532.01 109.94%
2019 253.41 0.00%
Rapporto P/E per aziende simili o concorrenti
Azienda P/E Ratio Differenza del P/E Ratio Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -280.38%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -275.78%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -207.84%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -205.37%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
Come leggere un P/E ratio?

Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.

Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.

Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.